The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
Identifieur interne : 000113 ( Pmc/Corpus ); précédent : 000112; suivant : 000114The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
Auteurs : Jeff Szer ; Daniel Weisdorf ; Sergio Querol ; Lydia Foeken ; Alejandro MadrigalSource :
- Bone Marrow Transplantation [ 0268-3369 ] ; 2020.
Url:
DOI: 10.1038/s41409-020-0873-x
PubMed: NONE
PubMed Central: 7091850
Links to Exploration step
PMC:7091850Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage</title><author><name sortKey="Szer, Jeff" sort="Szer, Jeff" uniqKey="Szer J" first="Jeff" last="Szer">Jeff Szer</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0624 1200</institution-id><institution-id institution-id-type="GRID">grid.416153.4</institution-id><institution>Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,</institution></institution-wrap>Melbourne, VIC Australia</nlm:aff></affiliation></author><author><name sortKey="Weisdorf, Daniel" sort="Weisdorf, Daniel" uniqKey="Weisdorf D" first="Daniel" last="Weisdorf">Daniel Weisdorf</name><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="ISNI">0000000419368657</institution-id><institution-id institution-id-type="GRID">grid.17635.36</institution-id><institution>Blood and Marrow Transplant Program and Masonic Cancer Center,</institution><institution>University of Minnesota,</institution></institution-wrap>Minneapolis, MN USA</nlm:aff></affiliation></author><author><name sortKey="Querol, Sergio" sort="Querol, Sergio" uniqKey="Querol S" first="Sergio" last="Querol">Sergio Querol</name><affiliation><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.438280.5</institution-id><institution>Frederic Duran i Jordà Center,</institution><institution>Catalan Blood and Tissue Bank (BST),</institution></institution-wrap>Barcelona, Spain</nlm:aff></affiliation></author><author><name sortKey="Foeken, Lydia" sort="Foeken, Lydia" uniqKey="Foeken L" first="Lydia" last="Foeken">Lydia Foeken</name><affiliation><nlm:aff id="Aff4">World Marrow Donor Association, Schipholweg 57, 2316 ZL Leiden, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Madrigal, Alejandro" sort="Madrigal, Alejandro" uniqKey="Madrigal A" first="Alejandro" last="Madrigal">Alejandro Madrigal</name><affiliation><nlm:aff id="Aff5"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0623 6380</institution-id><institution-id institution-id-type="GRID">grid.426412.7</institution-id><institution>Anthony Nolan Research Institute Royal Free Hospital & UCL Medical School,</institution></institution-wrap>London, UK</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmc">7091850</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091850</idno><idno type="RBID">PMC:7091850</idno><idno type="doi">10.1038/s41409-020-0873-x</idno><idno type="pmid">NONE</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000113</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000113</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage</title><author><name sortKey="Szer, Jeff" sort="Szer, Jeff" uniqKey="Szer J" first="Jeff" last="Szer">Jeff Szer</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0624 1200</institution-id><institution-id institution-id-type="GRID">grid.416153.4</institution-id><institution>Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,</institution></institution-wrap>Melbourne, VIC Australia</nlm:aff></affiliation></author><author><name sortKey="Weisdorf, Daniel" sort="Weisdorf, Daniel" uniqKey="Weisdorf D" first="Daniel" last="Weisdorf">Daniel Weisdorf</name><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="ISNI">0000000419368657</institution-id><institution-id institution-id-type="GRID">grid.17635.36</institution-id><institution>Blood and Marrow Transplant Program and Masonic Cancer Center,</institution><institution>University of Minnesota,</institution></institution-wrap>Minneapolis, MN USA</nlm:aff></affiliation></author><author><name sortKey="Querol, Sergio" sort="Querol, Sergio" uniqKey="Querol S" first="Sergio" last="Querol">Sergio Querol</name><affiliation><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.438280.5</institution-id><institution>Frederic Duran i Jordà Center,</institution><institution>Catalan Blood and Tissue Bank (BST),</institution></institution-wrap>Barcelona, Spain</nlm:aff></affiliation></author><author><name sortKey="Foeken, Lydia" sort="Foeken, Lydia" uniqKey="Foeken L" first="Lydia" last="Foeken">Lydia Foeken</name><affiliation><nlm:aff id="Aff4">World Marrow Donor Association, Schipholweg 57, 2316 ZL Leiden, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Madrigal, Alejandro" sort="Madrigal, Alejandro" uniqKey="Madrigal A" first="Alejandro" last="Madrigal">Alejandro Madrigal</name><affiliation><nlm:aff id="Aff5"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0623 6380</institution-id><institution-id institution-id-type="GRID">grid.426412.7</institution-id><institution>Anthony Nolan Research Institute Royal Free Hospital & UCL Medical School,</institution></institution-wrap>London, UK</nlm:aff></affiliation></author></analytic><series><title level="j">Bone Marrow Transplantation</title><idno type="ISSN">0268-3369</idno><idno type="eISSN">1476-5365</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="letter"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Bone Marrow Transplant</journal-id><journal-id journal-id-type="iso-abbrev">Bone Marrow Transplant</journal-id><journal-title-group><journal-title>Bone Marrow Transplantation</journal-title></journal-title-group><issn pub-type="ppub">0268-3369</issn><issn pub-type="epub">1476-5365</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">7091850</article-id><article-id pub-id-type="publisher-id">873</article-id><article-id pub-id-type="doi">10.1038/s41409-020-0873-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correspondence</subject></subj-group></article-categories><title-group><article-title>The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6783-2301</contrib-id><name><surname>Szer</surname><given-names>Jeff</given-names></name><address><email>Jeff.Szer@mh.org.au</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Weisdorf</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Querol</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Foeken</surname><given-names>Lydia</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Madrigal</surname><given-names>Alejandro</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0624 1200</institution-id><institution-id institution-id-type="GRID">grid.416153.4</institution-id><institution>Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,</institution></institution-wrap>Melbourne, VIC Australia</aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368657</institution-id><institution-id institution-id-type="GRID">grid.17635.36</institution-id><institution>Blood and Marrow Transplant Program and Masonic Cancer Center,</institution><institution>University of Minnesota,</institution></institution-wrap>Minneapolis, MN USA</aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.438280.5</institution-id><institution>Frederic Duran i Jordà Center,</institution><institution>Catalan Blood and Tissue Bank (BST),</institution></institution-wrap>Barcelona, Spain</aff><aff id="Aff4"><label>4</label>World Marrow Donor Association, Schipholweg 57, 2316 ZL Leiden, The Netherlands</aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0623 6380</institution-id><institution-id institution-id-type="GRID">grid.426412.7</institution-id><institution>Anthony Nolan Research Institute Royal Free Hospital & UCL Medical School,</institution></institution-wrap>London, UK</aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>3</month><year>2020</year></pub-date><fpage>1</fpage><lpage>2</lpage><history><date date-type="received"><day>5</day><month>3</month><year>2020</year></date><date date-type="rev-recd"><day>9</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>12</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>© Springer Nature Limited 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Health services</kwd><kwd>Infectious diseases</kwd></kwd-group></article-meta></front><body><sec id="Sec1"><title>To the Editor:</title><p id="Par1">The provision of donors for life-saving hematopoietic stem cell transplants is coordinated through registries and facilitated by the World Marrow Donor Association (WMDA), which operates a global database to find the best stem cell source. The database contains 36,214,535 donors and 790,357 cord blood units from 98 different registries in 53 different countries [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par2">The currently accelerating rate of COVID-19 infection and the responses of governments and facilities have the potential to impact and interfere with the timely provision of cells that must cross national borders. These cells are usually transported fresh after collection by individual or commercial couriers, while cord blood cells are transported while frozen though they still must be delivered promptly. In addition to transportation difficulties, possible exposures of the donor may affect the safety of the stem cell product. It is currently uncertain whether COVID-19 is transmissible parenterally, but it seems prudent to defer donors from endemic areas until suitable testing and observation time can ensure the safety of the product. This is particularly important if the donor is in a country or region with a high rate of COVID-19 infection. Donation may be precluded by available health resources diverted to the infection, perceived risks to couriers and the consequent delays in exporting and importing the product.</p><p id="Par3">A number of strategies have been proposed to assist in navigating through these rapidly evolving difficulties [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. Timely communication to donors and patients with strategies to assist in the provision of alternative products and procedures to optimize cell collections may be required. Pre-emptive cryopreservation of products that are likely to be required at a time when transport may be further restricted is one option. This would allow complete infectious testing to ensure that the product is not contaminated by infectious agents before use.</p><p id="Par4">In addition, there may a need to consider cord blood products more frequently as these products will have been collected and stored before the current infection became evident and cord blood units are always available immediately.</p><p id="Par5">Policy and practice considerations in these unprecedented circumstances are mandatory and registries need to work with responsible authorities to minimize interference with necessary medical treatment and facilitate any available alternatives when required.</p><p id="Par6">Organizations like WMDA could be vital to coordinate the urgent needs for cellular products. International cooperation and well-coordinated measures for donor provision will ensure that patients will be treated with the best product at the appropriate time.</p></sec></body><back><fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes notes-type="COI-statement"><title>Conflict of interest</title><p id="Par7">The authors declare that they have no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://statistics.wmda.info">https://statistics.wmda.info</ext-link> Accessed 4 March 2020.</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://share.wmda.info/x/ED6OF">https://share.wmda.info/x/ED6OF</ext-link> Accessed 4 March 2020.</mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://share.wmda.info/x/Yj6OF">https://share.wmda.info/x/Yj6OF</ext-link> Accessed 4 March 2020.</mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://share.wmda.info/display/LP/Coronavirus+-+Impact+on+Registry+Operations?preview=/344866402/344867270/WBMT_COVID-19-2.pdf#Coronavirus-ImpactonRegistryOperations-WorldwideNetworkForBlood&MarrowTransplantation(WBMT)">https://share.wmda.info/display/LP/Coronavirus+-+Impact+on+Registry+Operations?preview=/344866402/344867270/WBMT_COVID-19-2.pdf#Coronavirus-ImpactonRegistryOperations-WorldwideNetworkForBlood&MarrowTransplantation(WBMT)</ext-link> Accessed 4 March 2020.</mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000113 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000113 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:7091850
|texte= The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:NONE" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |